173 related articles for article (PubMed ID: 12680538)
1. Factors responsible for coverage and compliance in mass drug administration during the programme to eliminate lymphatic filariasis in the East Godavari District, South India.
Babu BV; Satyanarayana K
Trop Doct; 2003 Apr; 33(2):79-82. PubMed ID: 12680538
[TBL] [Abstract][Full Text] [Related]
2. Coverage, compliance and some operational issues of mass drug administration during the programme to eliminate lymphatic filariasis in Orissa, India.
Babu BV; Kar SK
Trop Med Int Health; 2004 Jun; 9(6):702-9. PubMed ID: 15189460
[TBL] [Abstract][Full Text] [Related]
3. Mass drug administration against lymphatic filariasis: experiences from Kozhikode district of Kerala State.
Regu K; Showkath Ali MK; Rajendran R; Koya SM; Ganesh B; Dhariwal AC; Lal S
J Commun Dis; 2006 Dec; 38(4):333-8. PubMed ID: 17913209
[TBL] [Abstract][Full Text] [Related]
4. A programme to eliminate lymphatic filariasis in Tamil Nadu state, India: compliance with annual single-dose DEC mass treatment and some related operational aspects.
Ramaiah KD; Das PK; Appavoo NC; Ramu K; Augustin DJ; Kumar KN; Chandrakala AV
Trop Med Int Health; 2000 Dec; 5(12):842-7. PubMed ID: 11169272
[TBL] [Abstract][Full Text] [Related]
5. Coverage and compliance of mass drug administration (MDA) programme for elimination of lymphatic filariasis in an endemic district of eastern Uttar Pradesh, India.
Bashar A; Nandekar SV; Shrivastava P; Singh RN; Srikrishnan P
J Vector Borne Dis; 2023; 60(3):307-316. PubMed ID: 37843242
[TBL] [Abstract][Full Text] [Related]
6. Knowledge on lymphatic filariasis and mass drug administration (MDA) programme in filaria endemic districts of Andhra Pradesh, India.
Mukhopadhyay AK; Patnaik SK; Satya Babu P; Rao KN
J Vector Borne Dis; 2008 Mar; 45(1):73-5. PubMed ID: 18399322
[No Abstract] [Full Text] [Related]
7. Strengthening of mass drug administration implementation is required to eliminate lymphatic filariasis from India: an evaluation study.
Lahariya C; Mishra A
J Vector Borne Dis; 2008 Dec; 45(4):313-20. PubMed ID: 19248659
[TBL] [Abstract][Full Text] [Related]
8. Use of an inclusive-partnership strategy in urban areas of Orissa, India, to increase compliance in a mass drug administration for the control of lymphatic filariasis.
Babu BV; Behera DK; Kerketta AS; Mishra S; Rath K; Swain BK; Mishra S; Kar SK
Ann Trop Med Parasitol; 2006 Oct; 100(7):621-30. PubMed ID: 16989688
[TBL] [Abstract][Full Text] [Related]
9. A campaign of "communication for behavioural impact" to improve mass drug administrations against lymphatic filariasis: structure, implementation and impact on people's knowledge and treatment coverage.
Ramaiah KD; Vijay Kumar KN; Hosein E; Krishnamoorthy P; Augustin DJ; Snehalatha KS; Nanda B; Das PK
Ann Trop Med Parasitol; 2006 Jun; 100(4):345-61. PubMed ID: 16762115
[TBL] [Abstract][Full Text] [Related]
10. Lymphatic filariasis in Andhra Pradesh Paper Mill Colony, Rajahmundry, India after nine rounds of MDA programme.
Mukhopadhyay AK
J Vector Borne Dis; 2010 Mar; 47(1):55-7. PubMed ID: 20231775
[No Abstract] [Full Text] [Related]
11. Coverage of, and compliance with, mass drug administration under the programme to eliminate lymphatic filariasis in India: a systematic review.
Babu BV; Babu GR
Trans R Soc Trop Med Hyg; 2014 Sep; 108(9):538-49. PubMed ID: 24728444
[TBL] [Abstract][Full Text] [Related]
12. A study to compare the effect of adding 12 days DEC regimen to 6 years annual mass drug administration to eliminate microfilaraemia infection in the community in rural Kanpur, Uttar Pradesh, India.
Kumar A; Sachan P; Bajpei A; Singh T
J Commun Dis; 2013; 45(1-2):33-40. PubMed ID: 25141552
[TBL] [Abstract][Full Text] [Related]
13. Elimination of lymphatic filariasis in India.
Sabesan S; Ravi R; Das PK
Lancet Infect Dis; 2005 Jan; 5(1):4-5. PubMed ID: 15620551
[No Abstract] [Full Text] [Related]
14. Impact of 10 years of diethylcarbamazine and ivermectin mass administration on infection and transmission of lymphatic filariasis.
Ramaiah KD; Das PK; Vanamail P; Pani SP
Trans R Soc Trop Med Hyg; 2007 Jun; 101(6):555-63. PubMed ID: 17374389
[TBL] [Abstract][Full Text] [Related]
15. School-based health education campaign--a potential tool for social mobilization to promote the use of DEC-fortified salt towards elimination of lymphatic filariasis.
Nandha B; Krishnamoorthy K
Health Educ Res; 2007 Aug; 22(4):539-46. PubMed ID: 17035351
[TBL] [Abstract][Full Text] [Related]
16. Coverage and awareness of and compliance with mass drug administration for elimination of lymphatic filariasis in Burdwan District, West Bengal, India.
Roy RN; Sarkar AP; Misra R; Chakroborty A; Mondal TK; Bag K
J Health Popul Nutr; 2013 Jun; 31(2):171-7. PubMed ID: 23930334
[TBL] [Abstract][Full Text] [Related]
17. Preventing confusion about side effects in a campaign to eliminate lymphatic filariasis.
Ramaiah KD; Ravi R; Das PK
Trends Parasitol; 2005 Jul; 21(7):307-8. PubMed ID: 15923141
[No Abstract] [Full Text] [Related]
18. Mass drug administration under the programme to eliminate lymphatic filariasis in Orissa, India: a mixed-methods study to identify factors associated with compliance and non-compliance.
Babu BV; Mishra S
Trans R Soc Trop Med Hyg; 2008 Dec; 102(12):1207-13. PubMed ID: 18632125
[TBL] [Abstract][Full Text] [Related]
19. Towards elimination of lymphatic filariasis: social mobilization issues and challenges in mass drug administration with anti-filarial drugs in Tamil Nadu, South India.
Nandha B; Krishnamoorthy K; Jambulingam P
Health Educ Res; 2013 Aug; 28(4):591-8. PubMed ID: 23503571
[TBL] [Abstract][Full Text] [Related]
20. Measuring impact on filarial infection status in a community study: role of coverage of mass drug administration (MDA).
Kumar A; Sachan P
Trop Biomed; 2014 Jun; 31(2):225-9. PubMed ID: 25134891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]